The approach uses an iteration of the SHERLOCK technology exclusively licensed to OraSure Technologies' subsidiary, Sherlock Biosciences.
Forecasting volcanic eruptions in time to alert authorities and populations remains a major global challenge. In a study ...
Despite major advances in genetic testing for breast cancer risk prediction, death rates remain disproportionately high among ...
Researchers at the Johns Hopkins Kimmel Cancer Center have developed a novel liquid biopsy approach to identify early-stage ...